Published in J Transl Med on November 22, 2016
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol (2007) 6.65
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res (2009) 3.83
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. J Clin Oncol (2011) 3.40
Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res (2003) 2.50
Antitumor vaccination: where we stand. Haematologica (2000) 2.30
12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci Rep (2012) 1.81
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med (1992) 1.76
Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res (2014) 1.63
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review. Haematologica (2006) 1.61
Animal models of tumor immunity, immunotherapy and cancer vaccines. Curr Opin Immunol (2004) 1.46
CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res (2010) 1.44
Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol (2011) 1.36
Cancer immunotherapy: the beginning of the end of cancer? BMC Med (2016) 1.32
Cancer metastases: challenges and opportunities. Acta Pharm Sin B (2015) 1.22
Translational research: 4 ways to fix the clinical trial. Nature (2011) 1.20
Chemoimmunotherapy: reengineering tumor immunity. Cancer Immunol Immunother (2013) 1.11
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene (2015) 1.07
Current role of FDG PET/CT in lymphoma. Eur J Nucl Med Mol Imaging (2014) 1.06
The interplay of immunotherapy and chemotherapy: harnessing potential synergies. Cancer Immunol Res (2015) 1.04
Murine models of B-cell lymphomas: promising tools for designing cancer therapies. Adv Hematol (2012) 1.01
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Mol Cancer Ther (2003) 0.94
Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma. J Gene Med (2007) 0.92
Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts. Oncol Rep (2015) 0.89
Immunotherapy and tumor microenvironment. Cancer Lett (2015) 0.88
[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model. Cancer Immunol Immunother (2006) 0.88
PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis. Adv Clin Exp Med (2015) 0.86
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol (2014) 0.85
Lymphoma Immunotherapy: Current Status. Front Immunol (2015) 0.84
A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells. Cancer Immunol Immunother (2009) 0.83
Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP. Cancer Chemother Pharmacol (2010) 0.82
Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect. Immunology (2014) 0.81
Evaluation of the specificity of [(18)F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [(18)F]FDG and impact of rituximab therapy. EJNMMI Res (2015) 0.80
Treatment of follicular lymphoma. J Clin Exp Hematop (2014) 0.80
A therapeutic vaccine using Salmonella-modified tumor cells combined with interleukin-2 induces enhanced antitumor immunity in B-cell lymphoma. Leuk Res (2012) 0.79
Studying cancer metastasis: Existing models, challenges and future perspectives. Crit Rev Oncol Hematol (2015) 0.77
Translational development of vaccination strategies in follicular NHL. Best Pract Res Clin Haematol (2011) 0.77
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk (2016) 0.77
Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies. Cancer Treat Res (2015) 0.77
Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes. Am J Blood Res (2014) 0.77